By Ali Roach

First, the good news: Opioid prescribing is at a 10-year low. The bad news? Overdose deaths are still at an all time high.

While tracking the dispensing of controlled substances is a critical piece of the puzzle, it is simply not enough to reduce substance abuse disorders.

According to this recent Health Data Management article, Questions Swirl on the Utility of current PDMP role in opioid crisis,“these databases need to be better integrated into clinical workflows and to provide more comprehensive, up-to-date data at the point of care.”

hc1 Tox Advisor, delivered via a strategic partnership with Appriss Health, was thoughtfully designed to meet this exact need.

The solution automatically compares toxicology results + PDMP data, providing real-time clinical decision support to personalize prescribing of controlled substances including opioids. hc1 Tox Advisor also complies with state PDMP regulations and satisfies all state-mandated use laws.

Now more than ever, prescribers require toxicology results to complement the PDMP by providing insight into drug consistency analysis. Equipped with the complete picture of each patient’s prescribing history and actual drug usage patterns, including illicit and non-prescribed drugs, prescribing physicians can make better decisions resulting in improved outcomes.

To learn more about hc1 Tox Advisor, download our new whitepaper: How your tox lab can outpace competitors with clinical decision support. 

Subscribe to the blog
Previous Post hc1-on-one: Women & Hi Tech Leading Light Award Nominee Brooke Brown